Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intravenous Treatment in Nursing Homes (3IV)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Morten Lindbaek, University of Oslo
ClinicalTrials.gov Identifier:
NCT01023763
First received: December 1, 2009
Last updated: May 12, 2016
Last verified: May 2016
  Purpose
The primary objective for the project is to evaluate whether nursing home residents who require intravenous fluids and intravenous antibiotics, can be treated just as well or even better in the nursing home as in the hospital. In Vestfold, Norway, a structured training program in the intravenous treatment of dehydration and infections in nursing homes is planned. The 3IV study will evaluate if this leads to an equal or better patient trajectory and reduced hospital admittance.

Condition Intervention Phase
Infections
Dehydration
Other: A structured training program
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Can a Structured Training Program in Intravenous Treatment of Infections in Nursing Homes Lead to a Better Patient Trajectory and Reduced Hospital Admittance?

Resource links provided by NLM:


Further study details as provided by University of Oslo:

Primary Outcome Measures:
  • All cause morbidity and mortality [ Time Frame: Within 30 days after disease onset ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Number of admissions and days in hospitals among nursing home residents [ Time Frame: Primarily within 30 days after disease onset ] [ Designated as safety issue: Yes ]
  • Patient trajectory [ Time Frame: Primarily within 30 days after disease onset ] [ Designated as safety issue: Yes ]
  • Satisfaction in patients, next of kin and staff [ Time Frame: Primarily within 30 days after disease onset ] [ Designated as safety issue: Yes ]

Enrollment: 330
Study Start Date: November 2009
Study Completion Date: December 2012
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Usual care

Nursing home residents who require intravenous fluids and intravenous antibiotics was treated as usual (hospital admissions for intravenous treatment).

In control nursing homes that had not completed the training program (intervention period), nursing home residents who require intravenous fluids and intravenous antibiotics was treated as usual. The majority of these patients were admitted to hospital for intravenous treatment. A few nursing homes or nursing home departments had sufficient expertise and capacity to provide treatment locally.

A training program in iv treatment

A structured training program in intravenous treatment in nursing homes:

Each of 30 participating nursing homes sequentially received theory and practical training in intravenous treatment. In nursing homes that had completed the training program (intervention period), and had sufficient expertise and capacity, nursing home residents in need of intravenous fluids or antibiotics were treated locally; otherwise they were hospitalized.

Other: A structured training program
A structured training program in nursing homes in the intravenous treatment of dehydration and infections.

Detailed Description:
  1. Can a structured training program in administration of intravenous fluids and antibiotics lead to a reduced number of admissions and days in hospitals among nursing home residents?
  2. Can treatment with intravenous fluids or antibiotics in nursing homes provide an equally good or better patient trajectory compared to patients hospitalized for the same treatment? We will look at duration of symptoms, direct and indirect complications, and mortality rates.
  3. Can treatment costs for the public health service be reduced when patients are treated with intravenous fluids and /or antibiotics in the nursing home instead of being admitted to the hospital?
  4. Can treatment for dehydration and infections in the nursing home rather than in a hospital provide an equally or better satisfaction in patients, next of kin and staff?
  5. How are difficult ethical issues handeld by medical staff at the nursing homes and the hospital when nursing home patients receive intravenous treatment?
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Nursing home residents in need of intravenous fluids or antibiotics

Exclusion Criteria:

  • Patients who needs hospitalization due to either co-morbidity or seriousness of disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01023763

Locations
Norway
University of Oslo
Oslo, Norway
Sponsors and Collaborators
University of Oslo
  More Information

Responsible Party: Morten Lindbaek, Professor, University of Oslo
ClinicalTrials.gov Identifier: NCT01023763     History of Changes
Other Study ID Numbers: 2009/1584a 
Study First Received: December 1, 2009
Last Updated: May 12, 2016
Health Authority: Norway: Data Protection Authority
Norway: Ministry of Health and Care Services
Norway:National Committee for Medical and Health Research Ethics
Individual Participant Data  
Plan to Share IPD: No

Keywords provided by University of Oslo:
Nursing homes
Intravenous
Treatment
Patient trajectory
Hospital admissions

Additional relevant MeSH terms:
Infection
Dehydration
Water-Electrolyte Imbalance
Metabolic Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on September 27, 2016